2m 2m 2m 2m 2m 2m 2m
VIRAX BIOLABS (VRAX)
NASDAQ
$3.15-$0.04 (-1.22%)
Price as of Aug 21, 2026 8:00 PM EDT- $326.9MMarket Cap
- -83.32%1-Year Change
- BiotechnologyIndustry
VIRAX BIOLABS (VRAX)
$3.15-$0.04 (-1.22%)
VRAX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.19 | ||
Change | -$0.26 (-7.54%) | ||
Open | $3.51 | ||
High | $3.51 | ||
Low | $3.14 | ||
Previous Close | $3.45 | ||
Volume | 120,587 | ||
30-Day Average Volume | 891,135 | ||
1-Week Change | 11.54% | ||
1-Month Change | -17.78% | ||
1-Year Change | -83.32% | ||
3-Year Change | -96.46% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 102.5M | ||
Total Assets | $8.3M | ||
Market Cap | $326.9M | ||
Enterprise Value | $320.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 06/26/2026 | ||
Earnings & Revenue